NEW YORK (GenomeWeb News) – OncoMethylome Sciences said today it will develop DNA methylation biomarkers for GlaxoSmithKline Biologicals that the drugmaker will use in its cancer immunotherapy program. 
The Belgian company will test its portfolio of methylation markers on clinical samples from GSK Biologicals, said OncoMethylome’s CTO, Jim DiGuiseppi.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.